Weiguo Dong
Impact in
- Toxicology top 0.5%
- Bioactive Compounds and Antitumor Agents
- Neurology top 2%
- Long-Term Effects of COVID-19
Papers in
-
- Gut microbiota and health 12
- Wnt/β-catenin signaling in development and cancer 9
- Oncology 46
- Co-authors
- Jixiang Zhang (61 shared papers)Dandan Wu (11 shared papers)Vikash Vikash (3 shared papers)Qing Ye (2 shared papers)Xiaoli Wang (6 shared papers)Yulan Liu (1 shared paper)Na Zhan (17 shared papers)Yu Xu (8 shared papers)
- Journals
- Digestive Diseases and Sciences (8 papers)PLoS ONE (8 papers)World Journal of Gastroenterology (7 papers)Medical Oncology (6 papers)Journal of Inflammation Research (6 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Weiguo Dong
192 papers receiving 6.1k citations
Weiguo Dong's Hit Papers
Peers
Comparison fields: 5 of 174
- Toxicology 224
- Neurology 655
- Cancer Research 636
- Complementary and alternative medicine 335
- Infectious Diseases 730
Countries citing papers authored by Weiguo Dong
This map shows the geographic impact of Weiguo Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiguo Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiguo Dong more than expected).
Fields of papers citing papers by Weiguo Dong
This network shows the impact of papers produced by Weiguo Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiguo Dong. The network helps show where Weiguo Dong may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiguo Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 195 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ROS and ROS‐Mediated Cellular Signaling Hit paper breakdown → | 2016 | 1515 |
| 2 | Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study Hit paper breakdown → | 2020 | 470 |
| 3 | Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China Hit paper breakdown → | 2020 | 461 |
| 4 | 2020 | 153 | |
| 5 | 2016 | 150 | |
| 6 | 2019 | 149 | |
| 7 | 2011 | 104 | |
| 8 | 2015 | 88 | |
| 9 | 2016 | 84 | |
| 10 | 2019 | 78 | |
| 11 | 2021 | 78 | |
| 12 | 2015 | 73 | |
| 13 | 2017 | 63 | |
| 14 | 2015 | 62 | |
| 15 | 2015 | 55 | |
| 16 | 2018 | 53 | |
| 17 | 2022 | 51 | |
| 18 | 2020 | 49 | |
| 19 | 2018 | 49 | |
| 20 | 2012 | 46 |
About Weiguo Dong
Weiguo Dong is a scholar working on Molecular Biology, Oncology, Surgery, Epidemiology and Genetics, having authored 195 papers that have together received 6.2k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (29 papers), Helicobacter pylori-related gastroenterology studies (20 papers), Liver Disease Diagnosis and Treatment (14 papers), Gastric Cancer Management and Outcomes (12 papers), Gut microbiota and health (12 papers), Microscopic Colitis (12 papers), Ferroptosis and cancer prognosis (9 papers) and Wnt/β-catenin signaling in development and cancer (9 papers). The work is most often cited by research in Toxicology (224 citations), Neurology (655 citations), Cancer Research (636 citations), Complementary and alternative medicine (335 citations) and Infectious Diseases (730 citations). Weiguo Dong has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Jixiang Zhang, Dandan Wu, Vikash Vikash, Qing Ye, Xiaoli Wang, Yulan Liu, Na Zhan, Yu Xu, Xufeng Guo and Shan Tian. Their work appears in journals such as Digestive Diseases and Sciences, PLoS ONE, World Journal of Gastroenterology, Medical Oncology and Journal of Inflammation Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.